Coca-Cola Europacific Partners (CCEP)
(Delayed Data from NSDQ)
$78.36 USD
+0.40 (0.51%)
Updated Oct 14, 2024 03:59 PM ET
After-Market: $78.35 -0.01 (-0.01%) 6:46 PM ET
2-Buy of 5 2
B Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.36 USD
+0.40 (0.51%)
Updated Oct 14, 2024 03:59 PM ET
After-Market: $78.35 -0.01 (-0.01%) 6:46 PM ET
2-Buy of 5 2
B Value B Growth C Momentum B VGM
Zacks News
FEMSA Buys a 40% Socofar Stake, Boosts Drugstore Operations
by Zacks Equity Research
FEMSA's (FMX) acquisition of the remaining 40% stake in Grupo Socofar is likely to bolster its drugstore business in South America and Mexico.
Constellation Brands (STZ) Beats on Q3 Earnings, Ups View
by Zacks Equity Research
Constellation Brands' (STZ) top and bottom lines beat estimates in third-quarter fiscal 2020 on strength in the beer business and improved margins. It raises earnings and cash flow guidance.
Molson Coors to Shut Irwindale Facility, Offers Pabst to Buy
by Zacks Equity Research
Molson Coors (TAP) expects to stop production at its Irwindale, CA-based brewery by September 2020. The move is in sync with its efforts to revitalize and restructure its business.
Weak Volumes & Cost Hurt Molson Coors, Growth Efforts on Track
by Zacks Equity Research
Molson Coors (TAP) is grappling with weakness in volumes and high input cost. However, the company's solid brand portfolio, premiumization efforts and cost-saving initiatives bode well.
FEMSA's (FMX) Unit Acquires AGV, Expands Footprint in Brazil
by Zacks Equity Research
FEMSA's (FMX) subsidiary, Solictica completes the acquisition of AGV. This is an important step for Solistica's Brazilian strategy.
Is Coca-Cola (CCEP) a Potential Stock for Value Investors?
by Zacks Equity Research
Let's see if Coca-Cola (CCEP) stock is a good choice for value-oriented investors right now from multiple angles.
CCEP or PEP: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CCEP vs. PEP: Which Stock Is the Better Value Option?
KOF vs. CCEP: Which Stock Is the Better Value Option?
by Zacks Equity Research
KOF vs. CCEP: Which Stock Is the Better Value Option?
Coca-Cola European (CCEP) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Coca-Cola European (CCEP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Soft Drinks Outlook: Can Portfolio Shift Bring Back the Fizz?
by Zacks Equity Research
The soft drinks space continues to struggle due to higher costs and soft carbonated-drinks sales. Meanwhile, companies' efforts to skew their portfolio toward health drinks and juices should help.
Keurig (KDP) Q4 Earnings In Line, Stock Slips on Soft View
by Zacks Equity Research
Keurig Dr Pepper (KDP) posts mixed fourth-quarter 2018 results, with sales missing estimates and earnings in line. A lower-than-expected earnings view for 2019 hurts investor sentiment.
PepsiCo to Boost Nutrition Portfolio With CytoSport Buyout
by Zacks Equity Research
PepsiCo (PEP) aims to fortify the nutrition brands portfolio with Hormel's CytoSport business, which produces Muscle Milk.
PepsiCo (PEP) Q4 Earnings In Line, Sales Beat Estimates
by Zacks Equity Research
PepsiCo (PEP) reports in-line earnings in fourth-quarter 2018 while sales top estimates. Strong performances in international divisions, along with strength in FLNA and NAB segments, boost results.
Coca-Cola (KO) Q4 Earnings In Line, Stock Slips on Soft View
by Zacks Equity Research
Coca-Cola (KO) delivers in-line earnings and sales in fourth-quarter 2018. However, concerns regarding increased impacts of currency fluctuations are likely to mar results in 2019.
CCEP or CCHGY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CCEP vs. CCHGY: Which Stock Is the Better Value Option?
What to Expect From These 5 Soft Drinks Stocks' Q4 Earnings?
by Zacks Equity Research
Let's see what is in store for a few soft drinks beverage stocks that are lined up for earnings releases this week.
Can Coca-Cola (KO) Keep Earnings Beat Trend Alive in Q4?
by Zacks Equity Research
Coca-Cola (KO) persistently gains from ongoing productivity efforts and disciplined growth strategies. Further, investment and innovation in the sparkling soft drinks category should aid results.
New Strong Buy Stocks for February 7th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Can Molson Coors (TAP) Brave Industry Woes in Q4 Earnings?
by Zacks Equity Research
Molson Coors (TAP) displays strength on the back of gains from cost-saving and premiumization efforts. However, soft industry trends, higher input costs and adverse currency remain concerns.
Avon (AVP) Eyes Turnaround, Reduces Headcount and Inventory
by Zacks Equity Research
Avon (AVP) moves ahead with the 'Open Up' Avon strategy as it plans to reset operating structure by reducing inventory levels and Stock Keeping Units, alongside lowering global headcount.
Diageo (DEO) Posts Strong 1H19 Earnings, Ups FY19 Sales View
by Zacks Equity Research
Diageo (DEO) reports strong top and bottom-line results for the first half of fiscal 2019, backed by solid organic growth. Further, the outlook for fiscal 2019 remains robust.
Coca-Cola Completes Buyout of Nigeria's Dairy & Juice Maker
by Zacks Equity Research
Coca-Cola (KO) acquires full stake in Nigeria's dairy and juice maker, Chi Ltd. Notably, Chi's diversified portfolio should aid the company's expansion in new categories and strengthen its business in Africa.
CCEP vs. CCHGY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CCEP vs. CCHGY: Which Stock Is the Better Value Option?
3 Soft Drinks Stocks With Potential to Beat Earnings in Q4
by Zacks Equity Research
The soft drinks industry's Q4 results might persistently bear the impact of soft CSD trends, and higher raw material and transportation costs. However, there are some potential winners in this space.
Why Coca-Cola European (CCEP) Could Beat Earnings Estimates Again
by Zacks Equity Research
Coca-Cola European (CCEP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.